FDA — authorised 16 August 2023
- Application: NDA215559
- Marketing authorisation holder: IPSEN
- Local brand name: SOHONOS
- Indication: CAPSULE — ORAL
- Status: approved
🇺🇸 Sohonos in United States
FDA authorised Sohonos on 16 August 2023
Marketing authorisation
Sohonos in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Bone approved in United States
Frequently asked questions
Is Sohonos approved in United States?
Yes. FDA authorised it on 16 August 2023.
Who is the marketing authorisation holder for Sohonos in United States?
IPSEN holds the US marketing authorisation.